Literature DB >> 3965477

The amplified expression of factors regulating myogenesis in L6 myoblasts.

W E Wright.   

Abstract

A strategy for increasing the expression of the factors regulating myogenesis was developed based upon the observation that increased amounts of regulatory factors could overcome the inhibition of differentiation produced by 5-bromodeoxyuridine (BUdR). L6 rat myoblasts were subjected to multiple cycles of cloning in progressively increasing concentrations of BUdR. The first clones to differentiate were picked and replated for the next cycle of selection. After 28 cycles in BUdR, cells were isolated that could differentiate in the presence of 8 microM BUdR. Cell hybrids between myoblasts subjected to 21 cycles of selection (BU21 cells) and differentiation-defective myoblasts exhibited a high probability of differentiation, consistent with the hypothesis that BU21 cells were overproducing factor(s) involved in the decision to differentiate. The selection of cells able to differentiate in the presence of BUdR may provide a general approach for increasing the expression of the regulatory molecules controlling terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965477      PMCID: PMC2113483          DOI: 10.1083/jcb.100.1.311

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  20 in total

1.  Insulin stimulates myogenesis in a rat myoblast line.

Authors:  J L Mandel; M L Pearson
Journal:  Nature       Date:  1974-10-18       Impact factor: 49.962

2.  The reversible control of animal cell differentiation by the thymidine analog, 5-bromodeoxyuridine.

Authors:  A W Coleman; J R Coleman; D Kankel; I Werner
Journal:  Exp Cell Res       Date:  1970-02       Impact factor: 3.905

3.  Induction of a deoxycytidineless state in cultured mammalian cells by bromodeoxyuridine.

Authors:  M Meuth; H Green
Journal:  Cell       Date:  1974-06       Impact factor: 41.582

4.  Identification of a developmental program using bromodeoxyuridine.

Authors:  H Weintraub; G L Campbell; H Holtzer
Journal:  J Mol Biol       Date:  1972-09-28       Impact factor: 5.469

5.  Inhibition of mammary gland differentiation in vitro by 5-bromo-2'-deoxyuridine.

Authors:  R W Turkington; G C Majumder; M Riddle
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

6.  The loss of phenotypic traits by differentiated cells, V. The effect of 5-bromodeoxyuridine on cloned chondrocytes.

Authors:  J Abbott; H Holtzer
Journal:  Proc Natl Acad Sci U S A       Date:  1968-04       Impact factor: 11.205

7.  Retention of differentiation potentialities during prolonged cultivation of myogenic cells.

Authors:  D Yaffe
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

8.  Analysis of variability in albumin content of sister hepatoma cells and a model for geometric phenotypic variability (quantitative shift model).

Authors:  J A Peterson
Journal:  Somat Cell Mol Genet       Date:  1984-07

9.  Quantitative phenotypic variation in single normal and malignant cells from liver and breast occurs along a geometric series.

Authors:  J A Peterson; W L Chaovapong; A A Dehgnan
Journal:  Somat Cell Mol Genet       Date:  1984-07

10.  Suppression of malignancy and differentiation in melanotic melanoma cells.

Authors:  S Silagi; S A Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  1970-05       Impact factor: 11.205

View more
  1 in total

1.  Expression of MyoD1 coincides with terminal differentiation in determined but inducible muscle cells.

Authors:  D Montarras; C Pinset; J Chelly; A Kahn; F Gros
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.